Rare pediatric Bednar tumor case highlights importance of histopathology and molecular testing in distinguishing uncommon dermatologic malignancies from benign pigmented lesions
The FDA's 2025 pulse oximetry guidance introduces stricter accuracy standards, larger study cohorts, and objective skin pigmentation assessment to address measurement bias in darker-skinned patients.
FDA approves a prefilled syringe format for Purified Cortrophin Gel, reducing administration steps for patients with inflammatory and autoimmune conditions.